Lobbying Information
Subject Matters
- Agriculture
- Consumer Issues
- Education
- Employment and Training
- Environment
- Fisheries
- Forestry
- Government Procurement
- Health
- Industry
- Intellectual Property
- International Trade
- Labour
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Proposed Amendments to Canada's Food and Drugs Act (former Bill C-51) as they relate to the licencing and post-market surveillance of pharmaceuticals, consumer health products and natural health products
Policies or Program
- Consultations on Canada's taxation policies relating to scientific research and experimental development tax credits as they apply to innovative pharmaceutical companies
- Consultations on Patented Medicine Prices Review Board's Excessive Price Guidelines with regard to proposed changes to reporting requirements and methodology for determining excessive prices.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Agriculture and Agri-Food Canada (AAFC)
-
Environment Canada
-
Finance Canada (FIN)
-
Foreign Affairs and International Trade Canada (DFAITC)
-
Health Canada (HC)
-
Human Resources and Social Development Canada (HRSDC)
-
Industry Canada
-
Members of the House of Commons
-
Natural Resources Canada (NRCan)
-
Patented Medicine Prices Review Board (PMPRB)
-
Pest Management Regulatory Agency (PMRA)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Revenue Canada (RC)
-
Senate of Canada
Government institutions added through a monthly communication report
In-house Corporation Details
Description of activities
Bayer Inc. ("Bayer") is a Canadian subsidiary of Bayer AG, an international research-based group with core businesses in health care, crop science, and innovative materials.Headquartered in Toronto, Ontario, Bayer Inc. operates the Bayer Group's HealthCare and MaterialScience businesses in Canada. Bayer CropScience Inc., headquartered in Calgary, Alberta operates as a separate legal entity in Canada. Together, the companies play a vital role in improving the quality of life for Canadians - producing products that fight diseases, protecting crops and animals, and developing high-performance materials for applications in numerous areas of daily life.
Responsible officer name and position during the period of this registration
Philip Blake,
President and Chief Executive Officer
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
77 Belfield Road
Toronto, ON M9W 1G6
Canada
Telephone number:
613-295-8406
Fax number:
416-240-5292
Parent Company Information
Subsidiary Beneficiary Information
Bayer Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Philip Blake,
President and Chief Executive Officer |
No public offices held
- Ute Bockstegers,
Chief Financial Officer |
No public offices held
- Mike Cels,
Head of Sales |
No public offices held
- Shurjeel Choudhri,
Head, Medical & Scientific Affairs |
No public offices held
- Jacqueline DeGagne,
Head - Law and Patents |
No public offices held
- Stefan Freeman,
Head - Animal Health Division |
No public offices held
- Doug Grant,
VP - Corporate Affairs |
No public offices held
- Gord Johnston,
Head - Human Resources |
No public offices held
- Kevin Skinner,
Head - Consumer Care Division |
No public offices held
- Ernie Springolo,
Country Representative - Bayer MaterialScience |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
